The tumor-agnostic treatment for patients with solid tumors: a position paper on behalf of the AIOM- SIAPEC/IAP-SIBioC-SIF Italian Scientific Societies-Reference-Cited by-同舟云学术

The tumor-agnostic treatment for patients with solid tumors: a position paper on behalf of the AIOM- SIAPEC/IAP-SIBioC-SIF Italian Scientific Societies

Published:2021-09 Issue: Volume:165 Page:103436
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Russo Antonio^ORCID,Incorvaia Lorena^ORCID,Malapelle Umberto,Del Re Marzia,Capoluongo Ettore,Vincenzi Bruno,Chiari Rita,Cortesi Laura,Danesi Romano^ORCID,Florena Ada Maria,Fontanini Gabriella,Gori Stefania,Marchetti Antonio,Normanno Nicola,Pinto Carmine,Sangiolo Dario^ORCID,Silvestris Nicola,Tagliaferri Pierosandro,Tallini Giovanni^ORCID,Cinieri Saverio,Beretta Giordano Domenico

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference97 articles.

1. From tissue-agnostic to N-of-One therapies: (R)Evolution of the precision paradigm;Adashek;Trends Cancer,2021

2. ETV6 rearrangements in patients with infantile fibrosarcomas and congenital mesoblastic nephromas by fluorescence in situ hybridization;Adem;Mod. Pathol.,2001

3. Analysis of Fusion Genes by NanoString System: A Role in Lung Cytology?;Alì;Arch. Pathol. Lab. Med.,2018

4. Homologous recombination deficiency in breast cancer: implications for risk, cancer development, and therapy;Ali;Genes Chromosomes Cancer,2020

5. Siena S. Gene fusions as novel targets of cancer therapy across multiple tumour types;Amatu;ESMO Open,2016

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Harnessing the potential of genomic characterization of mutational profiles to improve early diagnosis of lung cancer;Expert Review of Molecular Diagnostics;2024-09-12

2. The intersection of homologous recombination (HR) and mismatch repair (MMR) pathways in DNA repair-defective tumors;npj Precision Oncology;2024-09-05

3. Polθ: emerging synthetic lethal partner in homologous recombination-deficient tumors;Cancer Gene Therapy;2024-08-09

4. Anthracycline-related cardiotoxicity in patients with breast cancer harboring mutational signature of homologous recombination deficiency (HRD);ESMO Open;2024-01

5. Theranostic biomarkers and PARP-inhibitors effectiveness in patients with non-BRCA associated homologous recombination deficient tumors: Still looking through a dirty glass window?;Cancer Treatment Reviews;2023-12